Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 11:7:80.
doi: 10.3389/fvets.2020.00080. eCollection 2020.

Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases

Affiliations
Review

Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases

Brett D Story et al. Front Vet Sci. .

Abstract

Mouse models of human disease remain the bread and butter of modern biology and therapeutic discovery. Nonetheless, more often than not mouse models do not reproduce the pathophysiology of the human conditions they are designed to mimic. Naturally occurring large animal models have predominantly been found in companion animals or livestock because of their emotional or economic value to modern society and, unlike mice, often recapitulate the human disease state. In particular, numerous models have been discovered in dogs and have a fundamental role in bridging proof of concept studies in mice to human clinical trials. The present article is a review that highlights current canine models of human diseases, including Alzheimer's disease, degenerative myelopathy, neuronal ceroid lipofuscinosis, globoid cell leukodystrophy, Duchenne muscular dystrophy, mucopolysaccharidosis, and fucosidosis. The goal of the review is to discuss canine and human neurodegenerative pathophysiologic similarities, introduce the animal models, and shed light on the ability of canine models to facilitate current and future treatment trials.

Keywords: canine; gene therapy; large animal model; neurodegeneration; translational.

PubMed Disclaimer

References

    1. Haskins M. Gene therapy for lysosomal storage diseases (LSDs) in large animal models. ILAR J. (2009) 50:112–21. 10.1093/ilar.50.2.112 - DOI - PMC - PubMed
    1. Hoeppner MP, Lundquist A, Pirun M, Meadows JR, Zamani N, Johnson J, et al. . An improved canine genome and a comprehensive catalogue of coding genes and non-coding transcripts. PLoS ONE. (2014) 9:e91172. 10.1371/journal.pone.0091172 - DOI - PMC - PubMed
    1. Felsburg PJ. Overview of immune system development in the dog: comparison with humans. Hum Exp Toxicol. (2002) 21:487–92. 10.1191/0960327102ht286oa - DOI - PubMed
    1. Mendiola-Precoma J, Berumen LC, Padilla K, Garcia-Alcocer G. Therapies for prevention and treatment of Alzheimer's disease. BioMed Res Int. (2016) 2016:2589276. 10.1155/2016/2589276 - DOI - PMC - PubMed
    1. Kumar A, Tsao JW. Alzheimer Disease. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; (2019).

LinkOut - more resources